Vivos (RDGL) Receivables - Other (2010 - 2017)
Vivos' (RDGL) quarterly Receivables - Other came in at $137000.0 in Q4 2017, up 7.42% year-over-year from $127533.0 in Q4 2016, and little changed quarter-over-quarter from $137000.0 in Q3 2017.
Powered by 
Analysis
Vivos (RDGL) Receivables - Other (2010 - 2017) Analysis & Trends
Vivos has disclosed Receivables - Other across 4 years of filings, most recently posting $137000.0 for Q4 2017.
- In Q4 2017, Receivables - Other rose 7.42% year-over-year to $137000.0; the TTM figure through Dec 2017 stood at $137000.0 (up 7.42% YoY), while the FY2017 annual figure was $137000.0, up 7.42% from the prior year.
- Receivables - Other came in at $137000.0 for Q4 2017 at Vivos, roughly flat from $137000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $137000.0 in Q1 2017 to a low of $127533.0 in Q4 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | Vivos | 24.71 Mn | 24.71 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 137,000.00 |
| Sep 30, 2017 | 137,000.00 |
| Jun 30, 2017 | 137,000.00 |
| Mar 31, 2017 | 137,000.00 |
| Dec 31, 2016 | 127,533.00 |
| Dec 31, 2011 | 25,000.00 |
| Jun 30, 2011 | 125,000.00 |
| Mar 31, 2011 | 300,504.00 |
| Dec 31, 2010 | -41,675.00 |